PEAK6
REPL icon

PEAK6’s Replimune Group REPL Stock Holding History

PEAK6’s Portfolio REPL Stock Details REPL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$46.5K Buy
+4,202
New +$25.7K ﹤0.01% 2486

Other funds holding REPL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
RCI
Ridgeback Capital Investments Miami Beach, Florida $80.9M AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
FIS
FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return

PEAK6's REPL Position: Q2 2026 in Review

PEAK6 opened a new position in Replimune Group (REPL) in Q2 2026: 4,202 shares worth $46.5K. The stake represents ﹤0.01% of the portfolio and ranks #2486 among its holdings.

199 funds tracked by Wall St. Rank hold REPL as of Q2 2026.

  • PEAK6 held 4,202 shares of Replimune Group worth $46.5K as of Q2 2026.
  • Replimune Group was a new PEAK6 position in Q2 2026.
  • Replimune Group made up ﹤0.01% of PEAK6's portfolio in Q2 2026, its #2486 holding.
  • 199 funds tracked by Wall St. Rank held Replimune Group as of Q2 2026.

Based on PEAK6's 13F filing for Q2 2026, filed 13 Aug 2026.